NCT03599531View on ClinicalTrials.gov

Utility of the SomaLogic Cardiovascular Disease (CVD) Secondary Risk Panel for Cardiovascular Risk

CompletedOBSERVATIONAL
Enrollment

244

Participants

Timeline

Start Date

June 13, 2017

Primary Completion Date

October 10, 2020

Study Completion Date

October 10, 2020

Conditions
Cardiovascular Risk FactorCardiovascular Diseases
Trial Locations (1)

80301

Boulder Heart, Boulder

All Listed Sponsors
lead

SomaLogic, Inc.

INDUSTRY

NCT03599531 - Utility of the SomaLogic Cardiovascular Disease (CVD) Secondary Risk Panel for Cardiovascular Risk | Biotech Hunter | Biotech Hunter